Related Experiment Video
Updated: Jun 21, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Haemostaseologic effects of fractionated snake venoms]
L Béress1, I Bodendiek, W G Forssmann
1Abteilung für Immunologie, Klinische und Experimentelle Peptidchemie, Medizinische Hochschule Hannover.
Snake venom analysis reveals distinct effects: Elapidae venoms inhibit blood coagulation, while Viperidae venoms stimulate it. This research aids in selecting agents for anticoagulation or procoagulant therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Snake venoms are complex biological mixtures with diverse pharmacological activities.
- Understanding the hemostatic effects of different snake venom families is crucial for therapeutic applications.
Purpose of the Study:
- To comparatively analyze the hemostatic properties of venoms and venom fractions from Elapidae and Viperidae snakes.
- To identify potential therapeutic agents for anticoagulation and procoagulant therapy based on venom composition.
Main Methods:
- Gel filtration chromatography was employed for venom fractionation.
- Hemostatic analysis was performed on venom and fraction samples.
- Comparative investigation of coagulation profiles was conducted.
Main Results:
- Elapidae snake venoms predominantly exhibited inhibition of blood coagulation.
- Viperidae snake venoms were found to primarily stimulate blood coagulation.
- Distinct hemostatic profiles were observed between the two snake families.
Conclusions:
- The study provides a basis for selecting specific snake venom fractions for therapeutic purposes.
- Findings suggest potential applications of Elapidae fractions for anticoagulation and Viperidae fractions for procoagulant therapy in bleeding disorders.
More Related Videos
10:25Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis III: Interprofessional Care
Vascular Spasm
Hemorrhagic Stroke ll: Pathophysiology